Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity

Mucosal Immunology

Volumn 2, Issue 1, 2009, Pages 74-84

  Bonner, A ^a   Almogren, A ^b   Furtado, P B ^a   Kerr, M A ^c   Perkins, S J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN FC FRAGMENT; PROTEINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOGLOBULIN STRUCTURE; MUCOSAL IMMUNITY; NEUTRON SCATTERING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RADIATION SCATTERING; ULTRACENTRIFUGATION;

EID: 58049165638     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2008.68     Document Type: Article

References (45)

1. Kerr, M.A. The structure and function of human IgA. Biochem. J. 271, 285-296 (1990).
2. Mestecky, J., Moro, I., Kerr, M.A. & Woof, J.M. Mucosal immunoglobulins. In Mucosal Immunology 3rd edn (Mestecky J.R., Bienenstock J., Lamm M.E., Mayer L., McGhee J.R. & Strober W., eds) 153-181 (Chapter 9) (Academic Press, San Diego, CA, 2005).
3. Brandtzaeg, P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25, 5467-5484 (2007).
4. Crottet, P. & Corthésy, B. Mapping the interaction between murine IgA and murine secretory component carrying epitope substitutions reveals a role of domains II and III in covalent binding to IgA. J. Biol. Chem. 274, 31456-33146 (1999).
5. Lindh, E. Increased resistance of immunoglobulin A dimers to proteolytic degradation after binding of secretory component. J. Immunol. 114, 284-286 (1975).
6. Almogren, A., Senior, B.W., Loomes, L.M. & Kerr, M.A. Structural and functional consequences of cleavage of human secretory and human serum immunoglobulin A1 by proteinases from Proteus mirabilis and Neisseria meningitides. Infect. Immun. 71, 3349-3356 (2003).
7. Almogren, A., Senior, B.W. & Kerr, M.A.A comparison of the binding of secretory component to immunoglobulin A (IgA) in human colostral S-IgA1 and S-IgA2. Immunology 120, 273-280 (2007).
8. Perrier, C., Sprenger, N. & Corthésy, B. Glycans on secretory component participate in innate protection against mucosal pathogens. J. Biol. Chem. 281, 14280-14287 (2006).
9. Phalipon, A. & Corthésy, B. Novel functions of the polymeric Ig receptor: Well beyond transport of immunoglobulins. Trends Immunol. 24, 55-58 (2003).
10. Svehag, S.-E. & Bloth, B. Ultrastructure of secretory and high-polymer serum immunoglobulin A of human and rabbit origin. Science 168 847-849 (1970).
11. Bloth, B. & Svehag, S.-E. Further studies on the ultrastructure of dimeric IgA of human origin. J. Exp. Med. 133, 1035-1042 (1971).
12. Boehm, M.K., Woof, J.M., Kerr, M.A. & Perkins, S.J. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: A study by X-ray and neutron solution scattering and homology modelling. J. Mol. Biol. 286, 1421-1447 (1999).
13. Bonner, A., Perrier, C., Corthésy, B. & Perkins, S.J. The solution structure of human secretory component and implications for biological function. J. Biol. Chem. 282, 16969-16980 (2007).
14. Bonner, A., Furtado, P.B., Almogren, A., Kerr, M.A. & Perkins, S.J. Implications of the near-planar solution structure of human myeloma dimeric IgA1 for mucosal immunity and IgA nephropathy. J. Immunol. 180, 1008-1018 (2008).
15. Almogren, A., Furtado, P.B., Sun, Z., Perkins, S.J. & Kerr, M.A. Biochemical and structural properties of the complex between human immunoglobulin A1 and human serum albumin by X-ray and neutron scattering and analytical ultracentrifugation. J. Mol. Biol. 356, 413-431 (2006).
16. Perkins, S.J., Okemefuna, A.I., Fernando, A.N., Bonner, A., Gilbert, H.E. & Furtado, P.B. X-ray and neutron scattering data and their constrained molecular modelling. Mol. Cell Biol. 84, 375-423 (2008).
17. Cole, J.L., Lary, J.W., Moody, T.P. & Laue, T.M. Analytical ultracentrifugation: Sedimentation velocity and sedimentation equilibrium. Mol. Cell Biol. 84, 143-211 (2008).
18. Bjork, I. & Lindh, E. Gross conformation of human secretory immunoglobulin A and its component parts. Eur. J. Biochem. 45 135-145 (1974).
19. Woof, J.M. & Kerr, M.A. The function of immunoglobulin A in immunity. J. Pathol. 208, 270-282 (2006).
20. Heremans, J.F. Immunoglobulin A In The Antigens Vol. 2 (Sela, M., ed) 365-522 (Academic Press, New York, 1974).
21. Corthésy, B. Recombinant secretory immunoglobulin A in passive immunotherapy: Linking immunology and biotechnology. Curr. Pharm. Biotechnol. 4, 51-67 (2003).
22. Mestecky, J. & McGhee, J.R. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40, 153-245 (1987).
23. Fallgreen-Gebauer, E. et al. The covalent linkage of secretory component to IgA: Structure of sIgA. Biol. Chem. Hoppe Seyler. 374, 1023-1028 (1993).
24. Almogren, A. & Kerr, M.A. Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1 - implications in IgA-mediated disease. Mol. Immunol. 45, 87-94 (2008).
25. Herr, A.B., Ballister, E.R. & Bjorkman, P.J. Insights into IgA-mediated immune responses from the crystal structures of human FcaRI and its complex with IgA1-Fc. Nature 423, 614-620 (2003).
26. Perkins, S.J., Nealis, A.S., Sutton, B.J. & Feinstein, A. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modelling: A possible mechanism for complement activation. J. Mol. Biol. 221, 1345-1366 (1991).
27. Deisenhofer, J. Crystallographic refi nement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution. Biochemistry 20, 2361-2370 (1981).
28. Monteiro, R.C. & van de Winkel, J.G.J. IgA Fc receptors. Annu. Rev. Immunol. 21, 177-204 (2003).
29. Woof, J.M., van Egmond, M. & Kerr, M.A. Fc receptors. In Mucosal Immunology 3rd edn (Mestecky, J.R., Bienenstock, J., Lamm, M.E., Mayer, L., McGhee, J.R., & Strober, W., eds) 251-266 (Academic Press, San Diego, CA, 2005).
30. Mazengera, R.L. & Kerr, M.A. The specifi city of the IgA receptor purified from human neutrophils. Biochem. J. 272, 159-165 (1990).
31. Herr, A.B., White, C.L., Milburn, C., Wu, C. & Bjorkman, P.J. Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis. J. Mol. Biol. 327, 645-657 (2003).
32. Pleass, R.J., Dunlop, J.I., Anderson, C.M. & Woof, J.M. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fcα receptor (FcαRI CD89. J. Biol. Chem. 274, 23508-23514 (1999).
33. Brandtzaeg, P. & Prydz, H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 311, 71-73 (1984).
34. Johansen, F.-E., Braathen, R. & Brandzaeg, P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J. Immunol. 167, 5185-5192 (2001).
35. Brandtzaeg, P. Mucosal and glandular distribution of immunoglobulin components: Differential localization of free and bound SC in secretory epithelial cells. J. Immunol. 112, 1553-1559 (1974).
36. Bakos, M.-A., Kurosky, A. & Goldblum, R.M. Characterization of a critical binding site for human polymeric Ig on secretory component. J. Immunol. 147, 3419-3426 (1991).
37. Hamburger, A.E., West, A.P. & Bjorkman, P.J. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure 12, 1925-1935 (2004).
38. Norderhaug, I.N, Johansen, F.-E., Krajci, P. & Brandtzaeg, P. Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction. Eur. J. Immunol. 29, 3401-3409 (1999).
39. Beale, D. Differences in fragmentation between bound and unbound bovine secretory component suggest a model for its interaction with polymeric immunoglobulin. Biochem. J. 229, 759-763 (1985).
40. Crottet, P. & Corthesy, B. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab)2: A possible implication for mucosal defense. J. Immunol. 161, 5445-5453 (1998).
41. Sun, Z., Almogren, A., Furtado, P.B., Chowdhury, B., Kerr, M.A. & Perkins, S.J. Semi-extended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering. J. Mol. Biol. 353, 155-173 (2005).
42. Perkins, S.J. Protein volumes and hydration effects: The calculation of partial specific volumes, neutron scattering matchpoints and 280 nm absorption coeffi cients for proteins and glycoproteins from amino acid sequences. Eur. J. Biochem. 157, 169-180 (1986).
43. Narayanan, T., Diat, O. & Bosecke, P. SAXS and USAXS on the high brilliance beamline at the ESRF. Nucl. Instrum. Methods Phys. Res. A 467-468, 1005-1009 (2001).
44. Heenan, R.K., Penfold, J. & King, S.M. SANS at pulsed neutron sources: present and future prospects. J. Appl. Crystallogr. 30, 1140-1147 (1997).
45. Furtado, P.B. et al. Solution structure determination of human IgA2 by X-ray and neutron scattering and analytical ultracentrifugation and constrained modelling: A comparison with human IgA1. J. Mol. Biol. 338, 921-941 (2004).